classic.clinicaltrials.gov
ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days RSS plūsma
Saņem jaunākos atjauninājumus no ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days uzreiz, tiklīdz tie parādās.
Jaunākie ieraksti
Lasiet ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days tur, kur parasti lasāt
Cilvēki, kuri seko ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days, seko arī
-
Incyte Corporation SEC Filings investor.incyte.com
-
Astex astx.com
-
SUMITOMO PHARMA Co., Ltd. : News Releases sumitomo-pharma.com
-
Investor Relations | Karyopharm Therapeutics investors.karyopharm.com
-
-
Pegasys (peginterferon alfa-2a) - pharmaand GmbH ec.europa.eu
-
-
Press releases gsk.com
Vairāk RSS plūsmu, ko izpētīt
-
ClinicalTrials.gov: CLDN18.2 | Last update posted in the last 2 days classic.clinicaltrials.gov
-
-
Jautājumi
Kāda ir ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days RSS plūsmas URL adrese?
Plūsmas adrese ir https://classic.clinicaltrials.gov/ct2/results/rss.xml?rcv_d=14&lup_d=2&&sel_rss=new14&cond=%22myelofibrosis+%5C%28MF%5C%29%22+OR+%22Polycythemia+Vera+%5C%28PV%5C%29%22+OR+%22Essential+Thrombocythemia+%5C%28ET%5C%29%22+OR+%22Myeloproliferative+Neoplasm+%5C%28MPN%5C%29%22&count=10000. Ielīmējiet to jebkurā RSS lasītājā vai noklikšķiniet uz Sekot tagad, lai lasītu to Feeder.
Cik bieži ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days publicē ierakstus?
ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days publicē ierakstus aptuveni 5 reizes nedēļā. Pēdējais ieraksts tika publicēts pirms 4 dienas.
Vai ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days RSS plūsma darbojas?
Jā. Feeder to pārbaudīja pirms 1 minūte, un plūsma atbildēja kā parasti.
Kā sekot ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days pakalpojumā Feeder?
Noklikšķiniet uz Sekot tagad un reģistrējieties, ja jums vēl nav konta. Feeder bezmaksas plāns ietver līdz 200 plūsmām tīmeklī, iPhone un Android ierīcēs. Kredītkarte nav nepieciešama.
Sekojiet ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days pakalpojumā Feeder
Feeder bezmaksas plāns ietver līdz 200 plūsmām tīmeklī, iPhone un Android ierīcēs. Kredītkarte nav nepieciešama.